News Archives - November 2010


IU project will evaluate ovarian cancer drug for clinical trials   INDIANAPOLIS -- (Nov. 23, 2010) -- Indiana University will receive $900,000 from the Ovarian Cancer Research Fund (OCRF) to help prepare the new drug SGI-110 for clinical trials in patients whose once-thwarted ovarian cancer has returned.  More...Nov 23, 2010
Gene therapy for metastatic melanoma in mice produces complete remission, IU cancer researchers report   INDIANAPOLIS -- (Nov.18, 2010) -- A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation. The online version is now available. More...Nov 18, 2010
America's Top Doctors for Cancer recognizes 21 IU School of Medicine physicians   INDIANAPOLIS -- (Nov.12, 2010) -- Twenty-one physicians with the Indiana University School of Medicine have been recognized as the best in their field. More...Nov 12, 2010
IU spinoff company receives federal grant to continue drug development   INDIANAPOLIS -- (Nov. 4, 2010) -- ApeX Therapeutics, which is working on innovative molecularly-targeted treatments for cancer and eye disease based on Indiana University School of Medicine research, has received a federal grant of more than $150,000 to continue development of the therapies. More...Nov 04, 2010
Smokers, non-smokers: Talk to your doctor about your risks of lung cancer, IU Simon Cancer Center lung expert advises   INDIANAPOLIS -- (Nov. 1, 2010) -- November, designated Lung Cancer Awareness Month, is set aside to educate Americans about the deadliest -- and most preventable -- form of cancer.  More...Nov 01, 2010